Patient-Derived Bladder Cancer Xenografts

Patient-derived xenograft (PDX ) tumors are models developed by direct transplant of human tumors into immune-compromised hosts such as nude mice. These models retain the histological and genetic characteristics of the primary tumor and are considered a valuable platform for translational cancer res...

Full description

Saved in:
Bibliographic Details
Published inMethods in molecular biology (Clifton, N.J.) Vol. 1655; p. 169
Main Authors Bernardo, Carina, Santos, Lúcio Lara
Format Journal Article
LanguageEnglish
Published United States 2018
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Patient-derived xenograft (PDX ) tumors are models developed by direct transplant of human tumors into immune-compromised hosts such as nude mice. These models retain the histological and genetic characteristics of the primary tumor and are considered a valuable platform for translational cancer research. This chapter describes the methodology to establish and propagate bladder cancer PDX model.
AbstractList Patient-derived xenograft (PDX ) tumors are models developed by direct transplant of human tumors into immune-compromised hosts such as nude mice. These models retain the histological and genetic characteristics of the primary tumor and are considered a valuable platform for translational cancer research. This chapter describes the methodology to establish and propagate bladder cancer PDX model.
Author Santos, Lúcio Lara
Bernardo, Carina
Author_xml – sequence: 1
  givenname: Carina
  surname: Bernardo
  fullname: Bernardo, Carina
  email: carinadbernardo@gmail.com, carinadbernardo@gmail.com
  organization: Institute for Biomedicine (IBiMED), University of Aveiro, Porto, Portugal. carinadbernardo@gmail.com
– sequence: 2
  givenname: Lúcio Lara
  surname: Santos
  fullname: Santos, Lúcio Lara
  organization: Department of Surgical Oncology, Portuguese Oncology Institute-Porto (IPO-Porto), Porto, Portugal
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28889386$$D View this record in MEDLINE/PubMed
BookMark eNo1zstKAzEUgOGDKPaibyDSrYvoSXImOVnqeGmhoAsFd0MySWSkTcvMKPj2Curq2_38Mzgsu5IAziReSkR75SwLKchpJ6zSJLCRdABT6QiFQeUmMBuGd0SyWtExTBQzO81mChdPfuxSGcVt6rvPFBc3Gx9j6he1L-0Pr6ns3nqfx-EEjrLfDOn0zzm83N8910uxfnxY1ddr0arKkrDZIia2nqOMmaUhlXXQlGyF2biA3vkguVLBSjScDVVtjDkHJCbZajWH89_u_iNsU2z2fbf1_Vfz_6y-ARAyQoc
CitedBy_id crossref_primary_10_1016_j_biopha_2022_114154
crossref_primary_10_3233_BLC_180167
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1007/978-1-4939-7234-0_14
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
EISSN 1940-6029
ExternalDocumentID 28889386
Genre Journal Article
GroupedDBID ---
29M
53G
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
ECM
EIF
F5P
NPM
P2P
RSU
SPO
UDS
WH7
ZGI
ID FETCH-LOGICAL-c2574-7f700e87a8d1df81642f3b34e750f69b0a9ab1852b71068f645cddffb04841c32
IngestDate Fri May 24 00:01:15 EDT 2024
IsPeerReviewed false
IsScholarly true
Keywords In vivo
Tumorgraft
Animal models
Xenograft
Bladder cancer
Drug testing
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2574-7f700e87a8d1df81642f3b34e750f69b0a9ab1852b71068f645cddffb04841c32
PMID 28889386
ParticipantIDs pubmed_primary_28889386
PublicationCentury 2000
PublicationDate 2018-00-00
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – year: 2018
  text: 2018-00-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Methods in molecular biology (Clifton, N.J.)
PublicationTitleAlternate Methods Mol Biol
PublicationYear 2018
SSID ssj0047324
Score 2.2618384
Snippet Patient-derived xenograft (PDX ) tumors are models developed by direct transplant of human tumors into immune-compromised hosts such as nude mice. These models...
SourceID pubmed
SourceType Index Database
StartPage 169
SubjectTerms Animals
Antineoplastic Agents - pharmacology
Disease Models, Animal
Drug Evaluation, Preclinical
Drug Screening Assays, Antitumor
Heterografts
Humans
Male
Mice
Urinary Bladder Neoplasms - drug therapy
Urinary Bladder Neoplasms - pathology
Xenograft Model Antitumor Assays
Title Patient-Derived Bladder Cancer Xenografts
URI https://www.ncbi.nlm.nih.gov/pubmed/28889386
Volume 1655
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwEA9-IPgifn9LH3yRkdE2aZo8blMZYxs-bLC3kbQJCO6DMgT96700rStzivoSSlOSJr_c5e6Su0PolqaB8WOhsDBCYtjxI6A5ynAkGajPoUlSYx2ce33WHtLOKBqVudoL75KFqifva_1K_oMqvANcrZfsH5D9bBRewDPgCyUgDOWvMH5yQVHxPXT2CpJj88XykazWslBmtZGe2stXxgVrKkXQXp4zOr8GOylz49bKWEzuTNcsSjesTr1iKmha22GWzoqLIkXi7dw-Y1MR5yuia0_em43keVbrykxWjQoBrxgVtGOEwroF-EUXJadkUVRhdoFLsvKFCS_vXYB6KojAcUgoBmWDVj-HqZxPcmBC0MIFcRGxf65dCY1dVm2izZhbJte3phq3DdMYRMWKr-S637GRoIsmVrSKXLoY7KO9Qi3wGg7jA7Shp4doxyUKfTtCdytIewXSnkPaWyJ9jIaPD4NWGxdJLnAC3JLi2MS-r3kseRqkhoP2GhqiCNUgyhkmlC-FVNbDXYEsyLhhNEpSICAFrJcGCQlP0NZ0NtVnyGNKxZoIDvQXUcK1jDhnKQENXTDpc32OTt0Yx3MXyWRcjv7i25pLtLtcH1do2wDp6GuQwxbqJp_vD5ZAKgw
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Patient-Derived+Bladder+Cancer+Xenografts&rft.jtitle=Methods+in+molecular+biology+%28Clifton%2C+N.J.%29&rft.au=Bernardo%2C+Carina&rft.au=Santos%2C+L%C3%BAcio+Lara&rft.date=2018-01-01&rft.eissn=1940-6029&rft.volume=1655&rft.spage=169&rft_id=info:doi/10.1007%2F978-1-4939-7234-0_14&rft_id=info%3Apmid%2F28889386&rft_id=info%3Apmid%2F28889386&rft.externalDocID=28889386